ES468932A1 - Procedimiento para la preparacion de una proteina. - Google Patents

Procedimiento para la preparacion de una proteina.

Info

Publication number
ES468932A1
ES468932A1 ES468932A ES468932A ES468932A1 ES 468932 A1 ES468932 A1 ES 468932A1 ES 468932 A ES468932 A ES 468932A ES 468932 A ES468932 A ES 468932A ES 468932 A1 ES468932 A1 ES 468932A1
Authority
ES
Spain
Prior art keywords
protein
isolating
blood cells
red blood
proportion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES468932A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of ES468932A1 publication Critical patent/ES468932A1/es
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES468932A 1977-04-25 1978-04-19 Procedimiento para la preparacion de una proteina. Expired ES468932A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772718326 DE2718326A1 (de) 1977-04-25 1977-04-25 Neues protein und verfahren zu dessen herstellung

Publications (1)

Publication Number Publication Date
ES468932A1 true ES468932A1 (es) 1978-12-16

Family

ID=6007198

Family Applications (1)

Application Number Title Priority Date Filing Date
ES468932A Expired ES468932A1 (es) 1977-04-25 1978-04-19 Procedimiento para la preparacion de una proteina.

Country Status (17)

Country Link
US (1) US4297274A (es)
JP (1) JPS53133618A (es)
AT (1) AT366062B (es)
AU (1) AU516677B2 (es)
BE (1) BE866355A (es)
CA (1) CA1108535A (es)
DE (1) DE2718326A1 (es)
DK (1) DK176178A (es)
ES (1) ES468932A1 (es)
FR (1) FR2388825A1 (es)
GB (1) GB1603153A (es)
IE (1) IE46738B1 (es)
IT (1) IT7822621A0 (es)
LU (1) LU79511A1 (es)
NL (1) NL7804365A (es)
SE (1) SE7804713L (es)
ZA (1) ZA782330B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3013724A1 (de) * 1980-04-10 1981-10-15 Behringwerke Ag, 3550 Marburg Neues protein pp (pfeil abwaerts)9(pfeil abwaerts), verfahren zu seiner anreicherung und gewinnung sowieseine verwendung
US4378509A (en) * 1980-07-10 1983-03-29 Motorola, Inc. Linearized digital phase and frequency detector
WO1982003089A1 (en) * 1981-03-06 1982-09-16 Lennox Edwin Samuel Monoclonal antibody
FR2548670B1 (fr) * 1983-07-07 1985-10-25 Merieux Inst Procede de preparation des principales proteines du sang hemolyse sous forme non denaturee
DE3334405A1 (de) * 1983-09-23 1985-04-04 Behringwerke Ag, 3550 Marburg Membranassoziierte proteine (mp(pfeil abwaerts)2(pfeil abwaerts)), verfahren zu ihrer gewinnung sowie ihre verwendung
DE3418888A1 (de) * 1984-05-21 1985-11-21 Behringwerke Ag, 3550 Marburg Gewebeprotein pp(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts), verfahren zu seiner gewinnung sowie seine verwendung
JPS6178726A (ja) * 1984-09-27 1986-04-22 Asahi Medical Kk リウマチ特異蛋白質の精製法
US8927508B2 (en) * 2007-11-14 2015-01-06 Vgx Pharmaceuticals, Inc. Antibody production elicited by a DNA vaccine delivered by electroporation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904751A (en) * 1970-12-22 1975-09-09 Behringwerke Ag Process for isolating a fibrin stabilizing factor from human placenta
US3931399A (en) * 1970-12-22 1976-01-06 Behringwerke Aktiengesellschaft Process for isolating a fibrin-stabilizing factor
US4065445A (en) * 1971-09-29 1977-12-27 Behringwerke Aktiengesellschaft Pregnancy-specific β1 -glycoprotein and process for isolating it
DE2221261A1 (de) * 1972-04-29 1973-11-15 Behringwerke Ag Ap-glykoproteine und verfahren zu ihrer isolierung
DE2353973C3 (de) * 1973-10-27 1979-10-04 Behringwerke Ag, 3550 Marburg Steroid-bindendes Globulin und Verfahren zu dessen Herstellung
US3910822A (en) * 1974-03-14 1975-10-07 Us Health Isolation of glucocerebrosidase from human placental tissue
DE2445677C2 (de) * 1974-09-25 1982-09-16 Behringwerke Ag, 3550 Marburg Hochmolekulares alpha-Globulin und Verfahren zu dessen Herstellung

Also Published As

Publication number Publication date
SE7804713L (sv) 1978-10-26
CA1108535A (en) 1981-09-08
LU79511A1 (de) 1978-11-28
DE2718326A1 (de) 1978-10-26
IE780802L (en) 1978-10-25
NL7804365A (nl) 1978-10-27
BE866355A (fr) 1978-10-25
JPS53133618A (en) 1978-11-21
AU3540478A (en) 1979-11-01
AU516677B2 (en) 1981-06-18
DK176178A (da) 1978-10-26
GB1603153A (en) 1981-11-18
IT7822621A0 (it) 1978-04-21
FR2388825A1 (fr) 1978-11-24
ATA292578A (de) 1981-07-15
IE46738B1 (en) 1983-09-07
US4297274A (en) 1981-10-27
ZA782330B (en) 1979-04-25
AT366062B (de) 1982-03-10

Similar Documents

Publication Publication Date Title
Vanky et al. Serum-mediated inhibition of lymphocyte stimulation by autochthonous human tumors
IE780912L (en) A glycoprotain and process for the production thereof
Mauff et al. The nomenclature of properdin factor B allotypes
AU6295680A (en) Facilitating examination of uncoagulated blood
ES8102726A1 (es) Procedimiento para la fabricacion de dispositivos de ensayo para la deteccion de enzimas esteroliticas y-o proteoliticasespecialmente esterasas y-o proteasas de leucocitos
AU8172094A (en) Synthetic HTLV-III peptides, compositions and uses thereof
JPS5517492A (en) Production of biological composition used as serum standard composition for diagnostic analysis
ES470653A1 (es) Procedimiento para el enriquecimiento de una glicoproteina
Damber et al. Inhibition of the mixed lymphocyte reaction by the pregnancy zone protein
ES468932A1 (es) Procedimiento para la preparacion de una proteina.
EP0060491A3 (en) Protein pp16, process for concentrating and isolating it, and its use
EP0248534A3 (en) Method of detecting aids virus infection
IL61641A (en) Human cancer cell associated antigens,their preparation and purification,a diagnostic kit comprising antibodies thereto and its use for immunological detection of cancer
Guttman et al. Significance of cephalin-cholesterol flocculation test in malarial fever
ES468931A1 (es) Procedimiento para la preparacion de una glucoproteina de suero humano.
Ooi Histamine suppresses in vitro synthesis of precursor (pro-C5) of the fifth complement component (C5) by mouse peritoneal macrophages.
Aarli Binding of γ-globulin fragments to muscle tissue
Labib et al. Immunosuppressive factors in mouse amniotic fluid and neonate serum
Luthra et al. Lack of association of HLA‐A and B locus antigens with relapsing polychondritis
EP0282018A3 (en) Process for isolating basal membrane proteins from human or animal tissues
Puppo et al. β2‐μ‐free HLA class I heavy chain levels in sera of healthy individuals. Lack of association with β2‐μ‐associated HLA class I heavy chain levels and HLA phenotype
Jonsson et al. Immune complexes and complement components in Bell’s palsy
AU7160887A (en) Antiparatypical antibodies, their use for detecting and treating auto-immune diseases
Tönnessen et al. Complement factors and acute phase reactants in the Guillain-Barré syndrome
EP0248147A3 (en) Method of determining the presence of cancer cells